48 related articles for article (PubMed ID: 38632467)
1. Knockdown of heat shock protein family D member 1 (HSPD1) in lung cancer cell altered secretome profile and cancer-associated fibroblast induction.
Aluksanasuwan S; Somsuan K; Ngoenkam J; Chiangjong W; Rongjumnong A; Morchang A; Chutipongtanate S; Pongcharoen S
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119736. PubMed ID: 38663552
[TBL] [Abstract][Full Text] [Related]
2. TIMM17A overexpression in lung adenocarcinoma and its association with prognosis.
Miao L; Wu D; Zhao H; Xie A
Sci Rep; 2024 Apr; 14(1):8840. PubMed ID: 38632467
[TBL] [Abstract][Full Text] [Related]
3. Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma.
Xu Z; Chen C
Biomed Res Int; 2021; 2021():6663990. PubMed ID: 34036102
[TBL] [Abstract][Full Text] [Related]
4. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z
Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605
[TBL] [Abstract][Full Text] [Related]
5. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H
Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546
[TBL] [Abstract][Full Text] [Related]
6. Identification Six Metabolic Genes as Potential Biomarkers for Lung Adenocarcinoma.
Zhang S; Lu Y; Liu Z; Li X; Wang Z; Cai Z
J Comput Biol; 2020 Oct; 27(10):1532-1543. PubMed ID: 32298601
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
[No Abstract] [Full Text] [Related]
8. Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets.
Zhao P; Zhen H; Zhao H; Huang Y; Cao B
J Transl Med; 2023 Mar; 21(1):176. PubMed ID: 36879254
[TBL] [Abstract][Full Text] [Related]
9. Cancer statistics, 2023.
Siegel RL; Miller KD; Wagle NS; Jemal A
CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
[TBL] [Abstract][Full Text] [Related]
10. The prognostic index of m
Huang X; Zhu B; Qian C; Feng Y
Sci Rep; 2022 Dec; 12(1):21282. PubMed ID: 36482181
[TBL] [Abstract][Full Text] [Related]
11. Big data in basic and translational cancer research.
Jiang P; Sinha S; Aldape K; Hannenhalli S; Sahinalp C; Ruppin E
Nat Rev Cancer; 2022 Nov; 22(11):625-639. PubMed ID: 36064595
[TBL] [Abstract][Full Text] [Related]
12. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; D'Amico TA; DeCamp M; Dilling TJ; Dowell J; Gettinger S; Grotz TE; Gubens MA; Hegde A; Lackner RP; Lanuti M; Lin J; Loo BW; Lovly CM; Maldonado F; Massarelli E; Morgensztern D; Ng T; Otterson GA; Pacheco JM; Patel SP; Riely GJ; Riess J; Schild SE; Shapiro TA; Singh AP; Stevenson J; Tam A; Tanvetyanon T; Yanagawa J; Yang SC; Yau E; Gregory K; Hughes M
J Natl Compr Canc Netw; 2022 May; 20(5):497-530. PubMed ID: 35545176
[TBL] [Abstract][Full Text] [Related]
13. SNORD1C maintains stemness and 5-FU resistance by activation of Wnt signaling pathway in colorectal cancer.
Liu Y; Zhao C; Wang G; Chen J; Ju S; Huang J; Wang X
Cell Death Discov; 2022 Apr; 8(1):200. PubMed ID: 35422067
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]